58.23USD-5.32%Mkt Cap: 10.46B $P/E: —1d ago
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory dia…
Industry Peers
Health Information Services$30.88BUSDP/E 33.8
$14.02BUSDP/E 92.8
$7.91BUSDP/E 35.4
$6.87BUSD
$5.42BUSD
$4.30BUSDP/E 33.5
$3.46BUSDP/E 161.7
$2.30BUSD
$2.04BUSDP/E 102.1
$1.68BUSD
$1.38BUSD
$1.23BUSD
$1.05BUSD
$999.09MUSDP/E 49.2
$876.09MUSDP/E Infinity
$758.83MUSDP/E 35.8
$820.36MUSDP/E 41.9
$662.22MUSDP/E 67.0
$661.39MUSD
$544.92MUSDP/E 12.9
$551.39MUSD
$532.57MUSD
$516.62MUSD
$464.10MUSDP/E 26.4
$487.92MUSDP/E 55.5
$423.50MUSDP/E 23.7
$393.58MUSDP/E 90.5
$368.75MUSD
$323.50MUSD
$241.34MUSDP/E 14.7
$224.40MUSD
$217.64MUSDP/E 17.7
$156.03MUSDP/E 42.1
$169.22MUSD
$165.58MUSD
$150.13MUSDP/E 29.9
$131.08MUSDP/E Infinity
$120.28MUSDP/E 17.8
$99.86MUSDP/E 18.1
$110.79MUSDP/E 24.7
$88.19MUSD
$66.18MUSDP/E 11.4
$65.64MUSDP/E 23.8
$54.59MUSD
$52.80MUSD
$47.87MUSDP/E 57.6
$44.02MUSDP/E 42.0
$40.30MUSD
$33.58MUSD
$24.38MUSDP/E 58.3
$24.86MUSDP/E 24.0
$23.68MUSD
$18.43MUSD
$13.62MUSD
$13.30MUSD
$12.79MUSD
$9.78MUSDP/E 15.1
$9.41MUSD
$7.00MUSD
$6.27MUSD
$5.73MUSD
$5.39MUSD
$3.76MUSDP/E Infinity
$3.56MUSD
$3.57MUSDP/E 0.0
$3.21MUSD
$2.66MUSD
$2.16MUSDP/E Infinity
$899.8KUSDP/E 0.0
$629.5KUSD
$428.2KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap10.46B $
Enterprise Value11.72B $
Revenue (TTM)1.36B $
Gross Profit797.90M $
Net Income (TTM)-245.03M $
Revenue/Share7.735 USD
Last Price58.23 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.8K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-590.38
PEG—
EV/EBITDA-63.28
EV/Revenue8.59
P/S8.10
P/B26.47
EPS (TTM)-1.85
EPS (Forward)-0.10
52W Range
41.7326% of range104.32
52W High104.32 USD
52W Low41.73 USD
Profitability
Gross Margin62.74%
Oper. Margin-24.33%
EBITDA Margin-13.58%
Profit Margin-19.27%
ROE-49.87%
ROA-10.77%
Growth
Revenue Growth36.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-218.09M $
CapEx (TTM)27.27M $
FCF Margin-4.09%
FCF Yield-0.53%
Net Debt679.46M $
Net Debt/EBITDA-3.67
Balance Sheet
Debt/Equity2.70
Current Ratio3.31
Quick Ratio2.99
Book Value/Sh2.323 USD
Cash/Share3.559 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)66.06 USD
Upside (mean)+13.5%
Target Range35.00 USD – 100.00 USD
$35.00+13.5% to mean$100.00
# Analysts16
Ownership
Shares Out.174.52M
Float114.25M
Insiders37.12%
Institutions57.03%
Short Interest
Short Ratio5.4d
Short % Float38.44%
Short % Out.21.20%
Shares Short38.06M
Short (prev mo.)35.17M
Technical
SMA 5051.04 (+14.1%)
SMA 20062.67 (-7.1%)
Beta3.46
S&P 52W Chg20.11%
Avg Vol (30d)6.69M
Avg Vol (10d)6.74M
Technical Indicators
RSI (14)57.3
MACD2.9485
MACD Signal2.3608
MACD Hist.+0.5877
BB Upper64.54 USD
BB Middle54.37 USD
BB Lower44.21 USD
BB Width37.39%
ATR (14)4.061 USD
Vol Ratio (20d)0.66x